Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Article CommentaryCOMMENTARY
Open Access

Level of Evidence during the COVID-19 Pandemic: Making the Case for Case Series and Case Reports

I. Ikuta
American Journal of Neuroradiology July 2020, DOI: https://doi.org/10.3174/ajnr.A6676
I. Ikuta
aDepartment of Radiology & Biomedical ImagingYale University School of MedicineNew Haven, Connecticut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for I. Ikuta
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

I recently peer-reviewed case report and case series manuscripts of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19). Case reports and case series can lack the power to distinguish a statistically significant difference, which could hide a potential risk or benefit to diagnostic testing or treatment. The hierarchy of research evidence has worked its way into medical education and clinical practice. The research applied to clinical practice is often considered more trustworthy when using higher levels of research evidence (such as high-powered, prospective, randomized controlled trials or a meta-analysis of high-quality studies). Several national organizations, scientific panels, and clinical academies give case reports and case series some of their lowest rankings with regard to level of research evidence.1 Some journals have gone a step further and discontinued case reports, accepting only higher-level research study designs for publication. Academic promotions also consider the rigor of research, giving little credit for case reports and case series.

However, we still need case reports and case series. They provide us with data for rare diseases, as well as early news and potential clinical insights for evolving illnesses. Initial cases may provide the impetus for more organized, higher-level research. Higher-powered, prospective, randomized controlled trials provide a high quality of research evidence but may require funding, organization, and time to collect and analyze data, and a delay in information publication during a rapidly evolving global pandemic may not be optimal. A meta-analysis requires other research to be completed and published before one can even consider taking the time to do the meta-analysis. Applying higher levels of research evidence is absolutely vital to the practice of medicine, but lower levels of research evidence should not be dismissed.

During this COVID-19 pandemic, I have seen neuroimaging findings differ between separate case series. The astute radiologists and ordering clinicians may assimilate case series into their practice, realizing that the limitations will necessitate adaptation when additional information and better research become available. For example, the article “Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia?”2 found a lack of hemorrhage in their entire case series, but we have seen case reports and case series with petechial hemorrhage in patients with COVID-19.3,4 There were also no changes in enhancement or cerebral perfusion for this case series, but we have observed these changes in other reported cases.5 Publication of this case series2 without any hemorrhages, enhancement, or cerebral perfusion abnormality is not necessarily to contradict the literature, but instead adds data to the scientific community when we have a new illness in evolution. Combined with other publication findings, this case series2 will perhaps, in the future, help distinguish patient variables protective from hemorrhage (or clarify risk factors for hemorrhage) in COVID-19. Hopefully, these data motivate the clinical and scientific communities to do further research for better information so that one day we might have good knowledge for evidence-based medical practice and eventual medical wisdom.

In a busy clinical practice, it can be difficult to piece together the vast array of case series with inconsistent variables being reported. Maybe an ambitious researcher will tie it all together, perhaps with a meta-analysis. I remain hopeful that good evidence-based medical knowledge will eventually be available from high-level research evidence, but until then, careful incorporation of case reports and case series may have to suffice.

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    Committee on Standards for Developing Trust and Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press; 2011
  2. 2.↵
    1. Lang M,
    2. Buch K,
    3. Li MD, et al
    . Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia? AJNR Am J Neuroradiol 2020
  3. 3.↵
    1. Sachs JR,
    2. Gibbs KW,
    3. Swor DE, et al
    . COVID-19-associated leukoencephalopathy. Radiology 2020. May 14. [Epub ahead of print] doi:10.1148/radiol.2020201753 pmid:32407258
    CrossRefPubMed
  4. 4.↵
    1. Radmanesh A,
    2. Derman A,
    3. Lui YW, et al
    . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020202040 pmid:32437314
    CrossRefPubMed
  5. 5.↵
    1. Helms J,
    2. Kremer S,
    3. Merdji H, et al
    . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:32294339
    CrossRefPubMed
  • © 2020 by American Journal of Neuroradiology
PreviousNext
Back to top
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Level of Evidence during the COVID-19 Pandemic: Making the Case for Case Series and Case Reports
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Level of Evidence during the COVID-19 Pandemic: Making the Case for Case Series and Case Reports
I. Ikuta
American Journal of Neuroradiology Jul 2020, DOI: 10.3174/ajnr.A6676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Level of Evidence during the COVID-19 Pandemic: Making the Case for Case Series and Case Reports
I. Ikuta
American Journal of Neuroradiology Jul 2020, DOI: 10.3174/ajnr.A6676
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Seeing What We Expect to See in COVID-19
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Is Catheter Angiography Still Necessary to Evaluate Obliteration of Brain Arteriovenous Malformations Treated with Stereotactic Radiosurgery?
  • Is Transradial Access a Replacement Technique for Transfemoral Access in Neurointervention?
Show more Commentary

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire